Dr. Scott D. Segal

Psychiatry | Child and Adolescent Psychiatry
1065 Ne 125th St, Suite 206, 
North Miami, FL 
Accepting New Patients
Offers Telehealth
1065 Ne 125th St, Suite 206, 
North Miami, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Scott Segal is a Psychiatrist and a Child and Adolescent Psychiatrist in North Miami, Florida. Dr. Segal is rated as an Experienced provider by MediFind in the treatment of Alcoholic Neuropathy. His top areas of expertise are Schizoaffective Disorder, Bipolar Disorder (BPD), Schizophrenia, and Major Depression. Dr. Segal is currently accepting new patients.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Psychiatry
Child and Adolescent Psychiatry
Licenses
Psychiatry & Neurology in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

COMPASS HEALTH SYSTEMS PA
1065 Ne 125th St, Suite 206, North Miami, FL 33161

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
An Open-Label Extension Study of CM-AT for the Treatment of Children With Autism With All Levels of Fecal Chymotrypsin
Enrollment Status: Active_not_recruiting
Publish Date: February 13, 2025
Intervention Type: Drug
Study Drug: CM-AT Enzyme
Study Phase: Phase 3
A Double Blind, Randomized, Placebo-Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin (FCT)
A Double Blind, Randomized, Placebo-Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin (FCT)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Enrollment Status: Completed
Publish Date: October 15, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
A Phase 3, Open-label, Multicenter, 12-Month Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder
A Phase 3, Open-label, Multicenter, 12-Month Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Terminated
Publish Date: June 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Fixed-Dose, Efficacy, and Safety Study of SHP465 in Children Aged 6-12 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Phase 3, Randomized, Double-blind, Multicenter, Placebo-controlled, Fixed-Dose, Efficacy, and Safety Study of SHP465 in Children Aged 6-12 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
Enrollment Status: Completed
Publish Date: June 02, 2021
Intervention Type: Drug
Study Phase: Phase 3
An Open-label, Flexibly-dosed, Multicenter, Extension Study of Dasotraline to Evaluate Long-term Safety and Tolerability in Adults With Binge-eating Disorder
An Open-label, Flexibly-dosed, Multicenter, Extension Study of Dasotraline to Evaluate Long-term Safety and Tolerability in Adults With Binge-eating Disorder
Enrollment Status: Completed
Publish Date: August 12, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

3 Total Publications

Association Between Epidural Analgesia During Labor and Risk of Autism Spectrum Disorders in Offspring.
Association Between Epidural Analgesia During Labor and Risk of Autism Spectrum Disorders in Offspring.
Journal: JAMA pediatrics
Published: October 12, 2020
Similar Doctors
Experienced in Alcoholic Neuropathy
Dr. Krithika S. Iyer
Child and Adolescent Psychiatry | Psychiatry | Addiction Medicine
Experienced in Alcoholic Neuropathy
Dr. Krithika S. Iyer
Child and Adolescent Psychiatry | Psychiatry | Addiction Medicine

Fort Lauderdale Hospital Inc

5757 N Dixie Hwy, 
Oakland Park, FL 
 (21.4 miles away)
954-734-2000
Languages Spoken:
English, Hindi, Spanish, Tamil, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Krithika Iyer is a Child and Adolescent Psychiatrist and a Psychiatrist in Oakland Park, Florida. Dr. Iyer is rated as an Advanced provider by MediFind in the treatment of Alcoholic Neuropathy. Her top areas of expertise are Schizoaffective Disorder, Bipolar Disorder (BPD), Schizophrenia, and Major Depression. Dr. Iyer is currently accepting new patients.

Experienced in Alcoholic Neuropathy
Dr. Lissette D. Cortazar
Psychiatry | Geriatrics
Experienced in Alcoholic Neuropathy
Dr. Lissette D. Cortazar
Psychiatry | Geriatrics

Lissette D Cortazar Mdpa

3661 S Miami Ave, Suite 402, 
Miami, FL 
 (10.6 miles away)
305-815-0055
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Lissette Cortazar is a Psychiatrist and a Geriatrics provider in Miami, Florida. Dr. Cortazar is rated as a Distinguished provider by MediFind in the treatment of Alcoholic Neuropathy. Her top areas of expertise are Major Depression, Seasonal Affective Disorder (SAD), Generalized Anxiety Disorder (GAD), and Bipolar Disorder (BPD). Dr. Cortazar is currently accepting new patients.

Experienced in Alcoholic Neuropathy
Dr. Sergey P. Litvinov
Psychiatry | Neurology
Experienced in Alcoholic Neuropathy
Dr. Sergey P. Litvinov
Psychiatry | Neurology
521 Leslie Dr, 
Hallandale Beach, FL 
 (7.8 miles away)
954-362-7570
Languages Spoken:
English, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Sergey Litvinov is a Psychiatrist and a Neurologist in Hallandale Beach, Florida. Dr. Litvinov is rated as an Advanced provider by MediFind in the treatment of Alcoholic Neuropathy. His top areas of expertise are Schizophrenia, Schizoaffective Disorder, Bipolar Disorder (BPD), and Major Depression. Dr. Litvinov is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Segal's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile